{"record_key":"ikshana-therapeutics-inc","identifier":"ikshana-therapeutics-inc","external_key":"0CD74B","title":"Ikshana Therapeutics, Inc.","summary":null,"url":"https://inventions.pitt.edu/startups/ikshana-therapeutics-inc","json_url":"https://inventions.pitt.edu/startups/ikshana-therapeutics-inc.json","object_key":"startups","description":"Ikshana Therapeutics is developing treatments for age-related disease, beginning with dry age-related macular degeneration. Its research aims to restore cellular maintenance processes that decline with age and contribute to retinal damage. The company's pipeline includes CRYBA1 gene therapy and a lipocalin-2 antibody program, bringing complementary approaches to protecting vision. [1]: https://www.ikshanatherapeutics.com/disease-targets [2]: https://www.ikshanatherapeutics.com/pipeline\nLed by Ronjon Nag and scientific co-founder Debasish Sinha, Ikshana connects life-sciences entrepreneurship with retinal biology and gene-therapy expertise. Sinha previously held an endowed ophthalmology research chair at the University of Pittsburgh, linking the company's work to Pitt's strength in vision research. [3]: https://www.ikshanatherapeutics.com/aboutus","attributes":[{"key":"website","label":"Website","values":["https://www.ikshanatherapeutics.com/"]},{"key":"sector","label":"Sector","values":["Therapeutics"]},{"key":"therapeutic_areas","label":"Therapeutic Areas","values":["Ophthalmology"]},{"key":"therapeutic_indications","label":"Therapeutic Indications","values":["Age-related macular degeneration"]},{"key":"founders","label":"Founders","values":["Ronjon Nag","Debasish Sinha"]}],"related":[]}